India remains behind other countries when it comes to offering affordable CAR T-cell therapy although this treatment uses modified immune cells to fight cancer effectively. In 2017 the United States permitted CAR T-cell therapy yet both China approved their version in 2021 and India has no domestic production of this vital cancer treatment as of now. Doctors use CAR T-cell …